Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

M. de Weers; Y-T Tai; M.S. van der Veer; J.M. Bakker; T. Vink; D.C.H. Jacobs; L.A. Oomen; M. Peipp; T. Valerius; J.W. Slootstra; T. Mutis; W.K. Bleeker; K.C. Anderson; H.M. Lokhorst; J.G.J. van de Winkel; P.W.H.I. Parren

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

M. de Weers, Y-T Tai, M.S. van der Veer, J.M. Bakker, T. Vink, D.C.H. Jacobs, L.A. Oomen, M. Peipp, T. Valerius, J.W. Slootstra, T. Mutis, W.K. Bleeker, K.C. Anderson, H.M. Lokhorst, J.G.J. van de Winkel, P.W.H.I. Parren

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1840-1848
Number of pages	9
Journal	Journal of Immunology
Volume	186
Issue number	3
Publication status	Published - 2011

Cite this

de Weers, M., Tai, Y.-T., van der Veer, M. S., Bakker, J. M., Vink, T., Jacobs, D. C. H., Oomen, L. A., Peipp, M., Valerius, T., Slootstra, J. W., Mutis, T., Bleeker, W. K., Anderson, K. C., Lokhorst, H. M., van de Winkel, J. G. J., & Parren, P. W. H. I. (2011). Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. Journal of Immunology, 186(3), 1840-1848.

@article{dfb18f9aa88b48bfafb6e46081a1fac2,

title = "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.",

author = "\{de Weers\}, M. and Y-T Tai and \{van der Veer\}, M.S. and J.M. Bakker and T. Vink and D.C.H. Jacobs and L.A. Oomen and M. Peipp and T. Valerius and J.W. Slootstra and T. Mutis and W.K. Bleeker and K.C. Anderson and H.M. Lokhorst and \{van de Winkel\}, J.G.J. and P.W.H.I. Parren",

year = "2011",

language = "English",

volume = "186",

pages = "1840--1848",

journal = "Journal of Immunology",

issn = "0022-1767",

publisher = "American Association of Immunologists",

number = "3",

}

de Weers, M, Tai, Y-T, van der Veer, MS, Bakker, JM, Vink, T, Jacobs, DCH, Oomen, LA, Peipp, M, Valerius, T, Slootstra, JW, Mutis, T, Bleeker, WK, Anderson, KC, Lokhorst, HM, van de Winkel, JGJ & Parren, PWHI 2011, 'Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.', Journal of Immunology, vol. 186, no. 3, pp. 1840-1848.

TY - JOUR

T1 - Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

AU - de Weers, M.

AU - Tai, Y-T

AU - van der Veer, M.S.

AU - Bakker, J.M.

AU - Vink, T.

AU - Jacobs, D.C.H.

AU - Oomen, L.A.

AU - Peipp, M.

AU - Valerius, T.

AU - Slootstra, J.W.

AU - Mutis, T.

AU - Bleeker, W.K.

AU - Anderson, K.C.

AU - Lokhorst, H.M.

AU - van de Winkel, J.G.J.

AU - Parren, P.W.H.I.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0022-1767

VL - 186

SP - 1840

EP - 1848

JO - Journal of Immunology

JF - Journal of Immunology

IS - 3

ER -